InvestorsHub Logo
Followers 32
Posts 3437
Boards Moderated 0
Alias Born 10/09/2007

Re: None

Wednesday, 10/17/2007 1:26:08 PM

Wednesday, October 17, 2007 1:26:08 PM

Post# of 261
What is fueling this advance?

Neurochem Inc. was extreamly repeat....(Extreamly) oversold after the FDA (Government agency) did not approve one of Neurochem drugs.

But one must have really looked closely at what was really unfolding within the circles of Neurochem Inc. and the Cabal of the drug industry.

Johnson and Johnson wanted a cut of the future action....

$40,000,000 buy in....by JNJ....

In my humble honest opinion...its way to early to sell....

Kiacta drug....is online..

Alzhemed (Tramiprosate) results has not been reviewed properly as of yet...

This very young horse has some awesome powerful new drugs that may make a huge inpact on our world.

And Johnson and Johnson understands that....very much so..

Just by studying the long term chart pattern (Monthly)

Its very clear from past history, Neurochem is trading way oversold to its past highs.

$26 range.....

$26 .......to $2.12 lowest point ever...

And you would sell your interest now?

Prince Charles of Johnson and Johnson is eyeing Neurochem Inc.//why?

New powerful drugs......

Technical factors ADX....Volume ect...MACD Neurochem Inc. is looking awesome..ready to march around the track.....

Don't sell Neurochem Inc. short...

Plenty of upside left..to unfold in my book..

Insiders still hold 30% of the shares...so insiders never sold out.....so thats confindence from management side..

The upside is to rewarding to close your interest now..

God bless......Go NRMX
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.